Michael Sela
Michael Sela · Science & Medicine
Immunologist who co-developed Copaxone for multiple sclerosis and pioneered synthetic antigens.
1924, Tomaszów Mazowiecki, Poland — 2022, Rehovot, Israel
Poland · Israel (Weizmann Institute of Science, Rehovot)
Michael Sela is recognized among Jewish contributors to Science & Medicine — Immunologist who co-developed Copaxone for multiple sclerosis and pioneered synthetic antigens.
Born to a Jewish family in Poland, Sela fled the coming Holocaust and eventually settled in Israel, becoming a leading immunologist and the sixth president of the Weizmann Institute. Using synthetic antigens he helped uncover the genetic control of the immune response, and he co-invented two blockbuster drugs: Copaxone for multiple sclerosis and Erbitux for cancer. His research opened new fields in immunology and gave patients concrete therapies.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Immunologist who co-developed Copaxone for multiple sclerosis and pioneered synthetic antigens.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Ruth Arnon
Jules Freund
Marc Feldmann
Stuart Schlossman
Jacques Joseph
